Durability of Viral Neutralization in Asymptomatic Coronavirus Disease 2019 for at Least 60 Days.
Antibodies, Neutralizing
/ blood
Antibodies, Viral
/ blood
Asymptomatic Diseases
COVID-19
/ epidemiology
COVID-19 Nucleic Acid Testing
Cohort Studies
Enzyme-Linked Immunosorbent Assay
Female
Health Personnel
Humans
Male
Neutralization Tests
SARS-CoV-2
/ immunology
Surveys and Questionnaires
Time Factors
Virginia
/ epidemiology
COVID-19
immunity
serologic test
Journal
The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675
Informations de publication
Date de publication:
28 05 2021
28 05 2021
Historique:
received:
09
02
2021
accepted:
11
03
2021
pubmed:
16
3
2021
medline:
8
6
2021
entrez:
15
3
2021
Statut:
ppublish
Résumé
A cohort consisting of asymptomatic healthcare workers donated temporal serum samples after infection with severe acute respiratory syndrome coronavirus 2. Analysis shows that all asymptomatic healthcare workers had neutralizing antibodies, that these antibodies persist for ≥60 days, and that anti-spike receptor-binding domain immunoglobulin G levels were correspondingly durable over the same time period.
Identifiants
pubmed: 33718952
pii: 6170961
doi: 10.1093/infdis/jiab140
pmc: PMC7989428
doi:
Substances chimiques
Antibodies, Neutralizing
0
Antibodies, Viral
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1677-1680Subventions
Organisme : NHLBI NIH HHS
ID : K23 HL153771
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG021334
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR003015
Pays : United States
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Références
J Clin Microbiol. 2020 Oct 21;58(11):
pubmed: 32826322
Nat Immunol. 2021 Jan;22(1):25-31
pubmed: 33154590
Nat Med. 2020 Jun;26(6):845-848
pubmed: 32350462
Science. 2020 Dec 4;370(6521):1227-1230
pubmed: 33115920
Signal Transduct Target Ther. 2020 Sep 2;5(1):180
pubmed: 32879307
J Clin Invest. 2020 Dec 1;130(12):6477-6489
pubmed: 32833687
Emerg Infect Dis. 2021 Jan;27(1):
pubmed: 33058753
JAMA Intern Med. 2021 May 1;181(5):672-679
pubmed: 33625463
Nat Commun. 2020 Nov 13;11(1):5752
pubmed: 33188207
Sci Immunol. 2020 Jun 11;5(48):
pubmed: 32527802
Nat Med. 2020 Aug;26(8):1200-1204
pubmed: 32555424
BMJ. 2021 Feb 2;372:n308
pubmed: 33531333
Science. 2020 Aug 21;369(6506):956-963
pubmed: 32540903
N Engl J Med. 2020 Sep 10;383(11):1085-1087
pubmed: 32706954
J Am Heart Assoc. 2021 Feb;10(5):e019506
pubmed: 33619984